Royce & Associates LP bought a new stake in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 305,361 shares of the insurance provider's stock, valued at approximately $15,738,000. Royce & Associates LP owned approximately 1.60% of AMERISAFE at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp grew its stake in AMERISAFE by 8.5% in the third quarter. State Street Corp now owns 811,561 shares of the insurance provider's stock valued at $39,223,000 after purchasing an additional 63,638 shares in the last quarter. Barclays PLC boosted its stake in shares of AMERISAFE by 365.6% during the 3rd quarter. Barclays PLC now owns 33,219 shares of the insurance provider's stock worth $1,605,000 after acquiring an additional 26,084 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of AMERISAFE by 70.6% during the 3rd quarter. Jane Street Group LLC now owns 41,299 shares of the insurance provider's stock worth $1,996,000 after acquiring an additional 17,084 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in shares of AMERISAFE by 6.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 5,882 shares of the insurance provider's stock worth $284,000 after acquiring an additional 381 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in shares of AMERISAFE by 1,328.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 5,914 shares of the insurance provider's stock worth $305,000 after acquiring an additional 5,500 shares in the last quarter. Hedge funds and other institutional investors own 97.41% of the company's stock.
AMERISAFE Stock Performance
Shares of AMSF traded up $0.41 during trading hours on Thursday, hitting $51.51. 74,257 shares of the company were exchanged, compared to its average volume of 105,967. The company has a market cap of $981.27 million, a PE ratio of 16.10 and a beta of 0.33. The firm's 50 day moving average is $50.46 and its 200-day moving average is $51.89. AMERISAFE, Inc. has a 52 week low of $41.97 and a 52 week high of $60.24.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last announced its earnings results on Wednesday, February 26th. The insurance provider reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.07. AMERISAFE had a return on equity of 16.50% and a net margin of 19.49%. The firm had revenue of $73.51 million during the quarter, compared to the consensus estimate of $77.37 million. As a group, equities analysts forecast that AMERISAFE, Inc. will post 2.45 earnings per share for the current fiscal year.
AMERISAFE Cuts Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Friday, March 7th will be paid a dividend of $0.39 per share. The ex-dividend date is Friday, March 7th. This represents a $1.56 annualized dividend and a yield of 3.03%. AMERISAFE's payout ratio is 53.98%.
AMERISAFE Company Profile
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Read More

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.